Overview
- 49 inspections across 49 sites are on record.
- 18 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-15.
At a glance
Inspections
49
Sites
49
Observations
18
Career since
Oct 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Claudia T. Martorell, M.D. | 15 Jun 2026 | Human Drugs | On file |
| Michael S. Chapman, M.D. | 15 May 2026 | Human Drugs | |
| Cogent Biosciences, Inc. | 24 Apr 2026 | Human Drugs | |
| Erica L. Mayer, M.D. | 27 Mar 2026 | Human Drugs | On file |
| Parexel International (MA) Corporation | 5 Mar 2026 | Human Drugs |
Sites inspected
Claudia T. Martorell, M.D.Springfield, United States1 insp.
Michael S. Chapman, M.D.Lebanon, United States1 insp.
Cogent Biosciences, Inc.Waltham, United States1 insp.
Erica L. Mayer, M.D.Boston, United States1 insp.
Parexel International (MA) CorporationAuburndale, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Matthew C Watson10 shared
Kent A Conforti6 shared
Jose A Torres3 shared
Agata E Libera1 shared
Michael Serrano1 shared
Full investigator report
Get the verbatim findings behind Meredith L Miller's 18 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site